Pfizer Share Price Gains Over 5% After Q2 FY27 Earnings Results: Total Income Up 13.2% YoY

On November 3, 2026, Pfizer Limited released its unaudited financial results for the quarter and half-year ending September 30, 2026, as per the exchange filings.  

The company reported a rise in total income and net profit, reflecting a strong financial performance over the period. 

Pfizer Q2 FY27 Earnings Results 

For the September 2026 quarter, Pfizer Limited's total income increased by 13.2% year-on-year (YoY) to ₹774.19 crore, compared to ₹684.19 crore in the same quarter of the previous year. Quarter-on-quarter (QoQ), this represents a 10.9% increase from ₹698.01 crore in June 2026.  

Net profit (PAT) saw a 65.7% YoY rise to ₹313.25 crore, up from ₹189.02 crore a year ago, and a 53.2% QoQ increase from ₹204.47 crore in June 2026. 

Half-Yearly Financial Overview 

For the half-year ending September 30, 2026, Pfizer Limited's total income rose by 8.7% YoY to ₹1,472.20 crore, compared to ₹1,354.41 crore in the corresponding period of the previous year. Net profit (PAT) for the same period increased by 36.0% YoY to ₹517.72 crore, up from ₹380.77 crore. 

Annual Financial Metrics 

For the fiscal year 2026, Pfizer Limited reported a total income of ₹2,707.60 crore and a net profit (PAT) of ₹722.43 crore.  

The company's financial position as of September 30, 2026, included total assets of ₹5,292.98 crore, with non-current assets at ₹1,268.42 crore and current assets at ₹4,024.56 crore. Total equity was reported at ₹4,385.41 crore, while total liabilities stood at ₹907.57 crore. 

Read More: Aether Industries Share Price in Focus; Q2 Revenue Rises 24%, Net Profit Grows 26%! 

Cash Flow and Exceptional Items 

Net cash generated from operating activities for the half-year was ₹358.99 crore, with profit before tax reported at ₹699.51 crore. Investing activities used ₹2.80 crore, and financing activities used ₹366.03 crore. Cash and cash equivalents closed at ₹92.82 crore. An exceptional gain of ₹132.06 crore was recorded due to a non-recurring payment from Pfizer Inc. USA. 

Pfizer Share Price Performance 

As of November 03, 2026, at 3:30 PM, Pfizer share price on NSE was closed at ₹3,821.60, up by 5.03% from the previous closing price. 

Conclusion 

Pfizer Limited's financial results for September 2026 show a 13.2% YoY increase in total income to ₹774.19 crore and a 65.7% YoY rise in net profit to ₹313.25 crore. The half-yearly results also reflect an 8.7% YoY income growth to ₹1,472.20 crore and a 36.0% YoY profit increase to ₹517.72 crore. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.